40 results
8-K
EX-99.2
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
cannabinoids and cannabinoid analogs, today announced the closing of its previously announced private placement with two healthcare-focused
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
cannabinoids, today announced that it has entered into a securities purchase agreement with two healthcare-focused institutional investors for the issuance
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
14 Nov 22
InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
5:44pm
a $6.0 million private placement with two healthcare-focused institutional investors. Based on the current forecast, which is subject to potential
424B3
64z y06ya
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-99.1
peejkp84t
23 Sep 22
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
4:53pm
8-K
EX-99.2
1lshu 4i5yr
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-99.1
no834d8ngholh6shl
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-99.1
exmdes3ft7 8ls4
10 Aug 22
InMed Announces Changes to its Board of Directors
8:12pm
8-K
EX-99.1
f3slmk3ibnfw51hm
6 Jun 22
InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
9:47pm
8-K
EX-99.1
0551ehek
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
ga3jb4qrk
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
2t7z5z ks
6 May 22
Regulation FD Disclosure
2:50pm
424B3
rlw kx4djeahlocjfx
25 Apr 22
Prospectus supplement
5:02pm
424B3
mt8re0ys78cytiqvb6
7 Apr 22
Prospectus supplement
4:46pm